Marca Mista depositada no INPI em 23/08/2023 por Newfoundland Diagnostics Ltd, processo nº 501789163, nas classes 05, 09, 10, 35, 44. Registro em vigor até 23/08/2033.
| Número do processo | 501789163 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Mista |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 23/08/2023 |
| Data da concessão | 20/05/2025 |
| Vigência até | 23/08/2033 |
| Titular | Newfoundland Diagnostics Ltd |
| UF · País | — · GB |
Pharmaceuticals; medical preparations; medical diagnostic reagents and test strips; medical diagnostic and testing preparations to detect and diagnose infectious diseases, viruses, fertility, pregnancy, ovulation, menopause, general health issues, sexual health issues, vitamin and iron deficiency, drug and alcohol use, influenza, HIV (human immunodeficiency virus), HPV (human papillomavirus), UTI (urinary tract infection), and COVID-19; pregnancy testing preparations; diagnostic testing materials for medical use; chemical preparations for testing blood for medical purposes; genetic identity tests comprised of reagents for medical purposes.;
Computer software; computer software applications for mobile devices; electronic publications (downloadable).;
Surgical, medical, and dental apparatus and instruments; medical testing apparatus and instruments; medical apparatus and instruments for infectious diseases, viruses, fertility, pregnancy, ovulation, menopause, general health issues, sexual health issues, vitamin and iron deficiency, drug and alcohol use, influenza, HIV (human immunodeficiency virus), HPV (human papillomavirus), UTI (urinary tract infection), and COVID-19, blood tests, eye tests, genetic testing.;
Retail and wholesale services in connection with the sale of pharmaceuticals, medical preparations, medical diagnostic reagents and test strips, medical diagnostic and testing preparations to detect and diagnose infectious diseases, viruses, fertility, pregnancy, ovulation, menopause, general health issues, sexual health issues, vitamin and iron deficiency, drug and alcohol use, influenza, HIV (human immunodeficiency virus), HPV (human papillomavirus), UTI (urinary tract infection), and COVID-19, pregnancy testing preparations, diagnostic testing materials for medical use, chemical preparations for testing blood for medical purposes, genetic identity tests comprised of reagents for medical purposes, surgical, medical, and dental apparatus and instruments, medical testing apparatus and instruments, medical apparatus and instruments for infectious diseases, viruses, fertility, pregnancy, ovulation, menopause, general health issues, sexual health issues, vitamin and iron deficiency, drug and alcohol use, influenza, HIV (human immunodeficiency virus), HPV (human papillomavirus), UTI (urinary tract infection), and COVID-19, blood tests, eye tests, genetic testing; marketing, advertising and publicity services; provision of on-line advertising space; operation and management of gift card, discount card and customer loyalty schemes.;
Medical services; medical laboratory testing and analysis services; medical assessments and screening; medical diagnostic services; medical consultation; medical and health services relating to DNA, genetics and genetic testing; alcohol and drug testing for substance abuse; health risk assessment surveys; mental health screening services; pre-employment medical and health screening testing services; providing information and advice in connection with the aforementioned services.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501789163 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas4 despacho(s) publicado(s) na Revista da Propriedade Industrial.
27.5.1 Letras apresentando um grafismo especial